Best GLP-1 discount programs and savings cards 2026

If you've recently been prescribed a GLP-1 medication like semaglutide, tirzepatide, or another GLP-1 agonist, you've likely experienced sticker shock at the pharmacy counter. Without insurance or assistance programs, these life-changing medications can cost anywhere from $900 to $1,500 per month—a price tag that forces many patients to choose between their health and their financial security. The good news? Pharmaceutical manufacturers, pharmacy benefit managers, and nonprofit organizations have created an extensive network of discount programs and savings cards specifically designed to help you afford these medications. In 2026, more options exist than ever before, and many programs have dramatically expanded their eligibility criteria. This comprehensive guide will walk you through the best available savings strategies so you can access the GLP-1 medication your doctor prescribed without devastating your budget.

Manufacturer Patient Assistance and Copay Programs

The pharmaceutical companies producing the most popular GLP-1 medications have invested heavily in patient assistance programs that can dramatically reduce your out-of-pocket costs. Novo Nordisk, the manufacturer of Ozempic and Wegovy, offers the Novo Nordisk PASSport Program, which provides eligible patients with substantial discounts or even completely free medication. Similarly, Eli Lilly's Lilly Cares program supports patients using Mounjaro and Zepbound, while Pfizer offers assistance for their GLP-1 offerings.

These manufacturer programs operate on a tiered system based on your household income and insurance status. Here's how the structure typically works:

• Uninsured patients earning below 300% of the federal poverty level may qualify for free or deeply discounted medication
• Underinsured patients with high deductibles or copays can access copay assistance cards that cap monthly costs at $0 to $250
• Insured middle-income earners can benefit from reduced copay amounts, often bringing costs down by 50% or more

One of the most significant changes in 2026 is that manufacturers have eliminated or substantially raised income caps for copay assistance programs. Previously, earning above $60,000 annually as an individual might disqualify you from assistance. Today, many programs have removed strict income limits entirely for their copay card offerings, meaning even households earning $100,000+ per year can access reduced costs if their insurance plan's copay is particularly high.

The application process has also been streamlined considerably. Most manufacturer programs allow you to apply online in under five minutes, with approval decisions often coming within 24 hours. Many programs now offer automatic enrollment through participating pharmacies—your pharmacist can initiate the application process right at the checkout counter, eliminating paperwork entirely.

A pro tip: contact your prescribing physician's office before your first fill. Many healthcare providers maintain relationships with manufacturer representatives who specialize in patient enrollment and can guide you through the process or even handle preliminary applications on your behalf. Pharmacy staff are equally valuable resources; they process these applications daily and can explain which program might offer you the maximum savings based on your specific insurance situation.

Third-Party Discount Cards and Pharmacy Programs

Beyond manufacturer assistance, several third-party platforms have emerged as powerful savings tools for GLP-1 medications. GoodRx, one of the largest prescription discount platforms, allows you to compare prices across thousands of pharmacies and access discount codes that can reduce GLP-1 medication costs by 10% to 40%, depending on your location and the specific medication. Users report saving an average of $150 to $400 per month using GoodRx alone.

Similarly, SingleCare and RxSaver offer competitive pricing across pharmacy chains. These platforms work by negotiating bulk discounts directly with pharmacies, then passing those savings to consumers. The key advantage of these services is that they're completely free to use and don't conflict with manufacturer assistance programs—you can often stack a pharmacy discount with a manufacturer copay card for even greater savings.

Major pharmacy chains have also launched their own savings initiatives. Walmart's GoodRx partnership offers specially negotiated prices on select GLP-1 medications, while CVS ExtraCare and Walgreens Balance Rewards members receive exclusive discounts on chronic disease medications, including GLP-1 agonists. Some patients report accessing tirzepatide through these programs for $300 to $500 monthly—a remarkable reduction from standard retail pricing.

Amazon Pharmacy has also entered this space, offering competitive pricing on GLP-1 medications with free delivery to your home. For patients without insurance or those with high deductibles, Amazon Pharmacy's prices are often 20% to 35% lower than traditional retail pharmacies.

The critical strategy here is to compare. Before filling your prescription at any pharmacy, spend five minutes checking prices across GoodRx, SingleCare, your insurance formulary, manufacturer programs, and your local pharmacy chains. The price difference between options can easily exceed $500 per month.

Insurance Coverage Optimization and Nonprofit Resources

If you have health insurance, your coverage strategy matters tremendously. Many commercial insurance plans now include GLP-1 medications on their formulary, though often with significant restrictions like prior authorization requirements or step therapy (requiring you to try less expensive diabetes medications first). Working proactively with your insurance provider and healthcare team can unlock substantial savings.

Request a detailed formulary review from your insurance company's customer service line. Ask specifically about:

1. Whether your GLP-1 medication is covered and at what tier level
2. What your actual copay, coinsurance, or deductible will be
3. Whether prior authorization is required and what documentation your doctor must provide
4. Whether the manufacturer's copay assistance card can be used alongside your insurance plan

Additionally, several nonprofit organizations have dedicated resources to helping patients afford GLP-1 medications. The Diabetes Foundation and American Heart Association maintain databases of assistance programs and can connect you with resources based on your state and income level. The Patient Advocate Foundation offers free financial counseling specifically for medication affordability issues.

For 2026, some state Medicaid programs have expanded GLP-1 coverage beyond strict diabetes indications to include weight management, significantly broadening access for eligible patients. Contact your state's Medicaid office to determine your eligibility—expansion could mean your medication costs drop dramatically or become free entirely.

Frequently Asked Questions

Q: Can I use a manufacturer copay card if I have insurance?
A: Yes, in most cases. Manufacturer copay assistance cards are specifically designed to work alongside commercial insurance by reducing your out-of-pocket cost after insurance processes the claim. However, they typically cannot be used with Medicare, Medicaid, or TRICARE. Always confirm with the program before enrolling.

Q: How much can I realistically save using these programs?
A: Savings vary widely based on your situation, but typical patients report monthly out-of-pocket costs between $0 and $250 when using manufacturer programs or optimized insurance coverage, compared to $900-$1,500 without assistance. Over one year, that represents potential savings of $8,000 to $18,000 per patient.

Q: Do I need to reapply for assistance programs each month?
A: No. Most copay assistance cards remain valid for one year from approval and automatically renew unless your eligibility changes. However, it's wise to check your program status quarterly to ensure continuous coverage and maintain awareness of any program updates that might benefit you further.